SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-009824
Filing Date
2018-07-09
Accepted
2018-07-09 17:30:50
Documents
8
Period of Report
2018-07-06
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30373
2 ex3-1.htm EX-3.1 6470
3 ex99-1.htm EX-99.1 11178
4 ex3-1_001.jpg GRAPHIC 112950
5 ex3-1_002.jpg GRAPHIC 98446
6 ex3-1_003.jpg GRAPHIC 89214
7 ex3-1_004.jpg GRAPHIC 127582
8 ex3-1_005.jpg GRAPHIC 108321
  Complete submission text file 0001493152-18-009824.txt   788688
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53723 | Film No.: 18945480
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1